Corcept Therapeutics (CORT) EBT Margin Growth (1y) (2013 - 2026)
Corcept Therapeutics (CORT) EBT Margin Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1,526.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Corcept Therapeutics | 9.56 Bn | 9.22 Bn | 162.02 Mn | -3,323.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,323.00 |
| Dec 31, 2025 | -1,267.00 |
| Sep 30, 2025 | -2,166.00 |
| Jun 30, 2025 | -910.00 |
| Mar 31, 2025 | -1,772.00 |
| Dec 31, 2024 | -961.00 |
| Sep 30, 2024 | -43.00 |
| Jun 30, 2024 | -258.00 |
| Mar 31, 2024 | 639.00 |
| Dec 31, 2023 | 363.00 |
| Sep 30, 2023 | -301.00 |
| Jun 30, 2023 | -304.00 |
| Mar 31, 2023 | -1,121.00 |
| Dec 31, 2022 | -1,362.00 |
| Sep 30, 2022 | -532.00 |
| Jun 30, 2022 | -399.00 |
| Mar 31, 2022 | 359.00 |
| Dec 31, 2021 | 124.00 |
| Sep 30, 2021 | 841.00 |
| Jun 30, 2021 | -596.00 |